Your browser doesn't support javascript.
loading
LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.
Zhou, Yuying; Xiang, Jingjing; Bhandari, Adheesh; Wen, Jialiang; Lin, Bangyi; Kong, Lingguo; Wang, Ouchen.
Afiliação
  • Zhou Y; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Xiang J; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Bhandari A; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wen J; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Lin B; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Kong L; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wang O; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Clin Exp Pharmacol Physiol ; 47(4): 696-702, 2020 04.
Article em En | MEDLINE | ID: mdl-31855284
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Movimento Celular / RNA Antissenso / Progressão da Doença / Câncer Papilífero da Tireoide / Proteínas de Membrana Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Exp Pharmacol Physiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Movimento Celular / RNA Antissenso / Progressão da Doença / Câncer Papilífero da Tireoide / Proteínas de Membrana Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Exp Pharmacol Physiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China